Advertisement

Collaboration › Details
Bruker–SVB: investor conference, 202102 supply service Bruker presents at SVB Leerink Global Healthcare Conference
![]() |
Period | 2021-02-25 |
![]() |
Partner, 1st | Bruker Corporation (Nasdaq: BRKR) |
Group | Bruker (Group) | |
Partner, 2nd | SVB Leerink LLC | |
![]() |
Product | SVB Leerink Annual Global Healthcare Conference 2021 DIGITAL |
Product 2 | analytical instrument | |
![]() |
Person | Laukien, Frank H. (Bruker 201204 President + CEO) |
Person 2 | Minkova, Miroslava (Bruker Corp 201611 Head of Investor Relations) | |
Bruker Corporation. (2/22/21). "Press Release: Bruker Corporation to Present at Investor Conferences". Billerica, MA.
Bruker Corporation (Nasdaq: BRKR) announced today it will participate in the following virtual conferences:
10th Annual SVB Leerink Healthcare Conference
Thursday, February 25, 2021, at 8:40 a.m. Eastern Time
Frank Laukien, Chairman, President and Chief Executive Officer
Cowen 41st Annual Health Care Conference
Tuesday, March 2, 2021, at 11:10 a.m. Eastern Time
Gerald Herman, Chief Financial Officer
Live audio webcasts of the virtual “fireside chat” sessions will be available on the Investor Relations section of the Company's website at https://ir.bruker.com. Replays will be posted on Bruker’s Investor Relations website after each event and will be available for 30 days following the presentation.
About Bruker Corporation (Nasdaq: BRKR)
Bruker is enabling scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker’s high performance scientific instruments and high value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular and microscopic levels. In close cooperation with our customers, Bruker is enabling innovation, improved productivity and customer success in life science molecular and cell biology research, in applied and pharma applications, in microscopy and nanoanalysis, as well as in industrial applications. Bruker offers differentiated, high-value life science and diagnostics systems and solutions in preclinical imaging, clinical phenomics research, proteomics and multiomics, spatial and single-cell biology, functional structural and condensate biology, as well as in clinical microbiology and molecular diagnostics. For more information, please visit: www.bruker.com.
Miroslava Minkova
Director, Investor Relations & Corporate Development
Bruker Corporation
T: +1 (978) 663 – 3660, ext. 1479
E: Investor.Reations@bruker.com
Record changed: 2022-01-02 |
Advertisement
![Picture [iito] No Tracking 650x100px](/banner/iito-business-intelligence-20211013-650-100-summer-banner-series-no-tracking.jpg)
More documents for Bruker (Group)
- [1] IonSense, Inc.. (4/7/22). "Press Release: IonSense, a Leader In DART Mass Spectroscopy, Announces Acquisition by Bruker to Accelerate DART-MS Methods and Applications Development". New York, NY, London & Research Triangle Park, NC....
- [2] Bruker Corporation. (4/5/22). "Press Release: Bruker Acquires Optimal Companies for Pharma PAT Software and Biopharma Manufacturing Automation Expertise and Technologies". Billerica, MA....
- [3] Bruker Corporation. (1/19/22). "Press Release: Bruker Acquires Prolab Instruments to Augment Multiomics Solutions". Billerica, MA....
- [4] PreOmics GmbH. (1/18/22). "Press Release: PreOmics Announces Closing of Series B Financing to Accelerate Research, Development and Commercialization of Proteomics Tools and Consumables". Munich....
- [5] Bruker Corporation. (1/4/22). "Press Release: Bruker Corporation to Present at the 40th Annual J.P. Morgan Healthcare Conference". Billerica, MA....
- [6] Bruker Corporation. (11/19/21). "Press Release: Bruker Announces Acquisition of Molecubes NV". Ghent....
- [7] Bico Group AB. (11/16/21). "Press Release: Cellenion Announces Co-marketing Agreement with Bruker to Deliver Advanced Solutions for Single Cell Mass Spectrometry-based Proteomics Analysis"....
- [8] PreOmics GmbH. (11/1/21). "Press Release: PreOmics Launches BeatBox at ASMS 2021 for High Throughput Tissue Homogenization"....
- [9] Bruker Corporation. (6/1/21). "Press Release: Bruker Launches timsTOF trueSCP for Unbiased Single Cell 4D-Proteomics and Next-gen timsTOF Pro 2 with Unprecedented Proteomic Depth". Billerica, MA....
- [10] Numares AG. (3/24/21). "Press Release: Numares Announces FDA 510(k) Submission of Axinon System, a NMR Platform for Metabolomics-based, AI-driven Diagnostics". Boston, MA & Regensburg....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement

» top